DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
Current Location:
> This Story

Forward Printable StoryPrint Comment



Operating Room Homepage

First major study comparing robotic to open surgery published in The Lancet

Tenon Medical, Inc. receives FDA clearance for Sacroiliac Joint Fusion System

Keyhole may trump robotic surgery for mitral valve repair

More precise surgical tool for deep-brain stimulation offers a solution to waiting lists

TriStar Centennial Medical Center acquires the first Levó Head Positioning System by Mizuho OSI

Mazor Robotics’ Renaissance System installed at Georgia ASC

ECRI Institute announces new initiative to extinguish surgical fires

Intuitive Surgical announces innovative single port platform — the da Vinci SP Surgical System

Mt. Sinai utilizing ZEISS KINEVO 900 microscope for 4K and 3D visualization beyond the surface of the brain

Bittium and Cerenion announce collaboration on bringing next-generation brain monitoring to intensive care

Broncus Medical closes Series A financing from Intuitive Surgical

Press releases may be edited for formatting or style
SAN JOSE, Calif.--(BUSINESS WIRE)--Broncus Medical, Inc., developer of diagnostic and therapeutic technology for lung disease, today announced the closing of a Series A round of $15 million from Intuitive Surgical, the pioneer and a global technology leader in minimally invasive robotic-assisted surgery.

The three-pronged investment from Intuitive includes the equity investment, along with a technology development collaboration, and licensing of Broncus Medical’s intellectual properties, which can be utilized in the development of technologies focused on diagnostic and therapeutic lung procedures.

Story Continues Below Advertisement

OR Tables, Treatment/GYN/Uro Chairs, Transport Stretchers, Hospital/ICU Bed

iMS combines the superior service of Oakworks Medical and advanced manufacturing technology of FAMED Medical Solutions. The goal of iMS, "Connecting Art and Medical Science" goes way beyond product with exceptional CareLink service. Contact us today!

The fund will be used for continued product development of the company’s suite of lung cancer technologies and execution of clinical trials to support the commercial business. This includes execution of on-going EAST 2 (Evaluation of the Archimedes System for Transparenchymal Nodule Access 2), a Post-Market study that is currently enrolling up to 200 patients to validate performance of the company’s technology for total lung navigation and tumor access, and multiple feasibility studies of investigational technology to bronchoscopically treat lung cancer.

“We are delighted to build a relationship with an industry leader like Intuitive, that shares our vision of bringing greater visibility and precision to lung cancer diagnosis and treatment, in order to benefit patients,” said Broncus Holding Chairman Michael Zhao.

Broncus Medical has built a solid portfolio of intellectual properties and technologies to enable bronchoscopic access to nodules anywhere in the lung, as well as treatment for major lung diseases including lung cancer and emphysema. The company’s combined use of Fused Fluoroscopy, real-time bronchoscopy, and virtual bronchoscopic navigation provides a three-dimensional view within the lungs, improving accuracy and enabling a direct access to the nodule for diagnosis and treatment.

About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. (Nasdaq:ISRG), headquartered in Sunnyvale, Calif., is the pioneer and a global technology leader in robotic-assisted, minimally invasive surgery. Intuitive develops, manufactures and markets the da Vinci surgical system. The company strives to make surgery more effective, less invasive and easier on surgeons, patients and their families.

About Broncus Medical, Inc.
Broncus Medical, Inc. is dedicated to the development of diagnostic and therapeutic technology for lung disease. Founded in 2012, the company’s primary technology platforms focus on the diagnosis of lung cancer and the treatment of emphysema. Its lung cancer portfolio includes the Archimedes™ System, Archimedes™ Planner, LungPoint® Virtual Bronchoscopic Navigation (VBN) System, LungPoint® Planner and FleXNeedle®.

Back to HCB News
  Pages: 1

Operating Room Homepage

You Must Be Logged In To Post A Comment

Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Gold Service Dealer Program
Receive RFP/PS
Healthcare Providers
See all
HCP Tools
A Job
Parts Hunter +EasyPay
Get Parts
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to, Inc. Copyright ©2001-2018, Inc.